From: Plasma lipoproteome in Alzheimer’s disease: a proof-of-concept study
Plasma lipoprotein fraction | Peptide | Protein | Unadjusted p value | FDR adjusted p value | Fold-changes (controls/AD cases) |
---|---|---|---|---|---|
VLDL | IHWESASLLR | C3 | 7.4987E−05 | 0.009073469 | 1.25 |
IDL | TLDPER | C3 | 0.00116714 | 0.059597026 | 1.19 |
IDL | IHWESASLLR | C3 | 0.00116857 | 0.059597026 | 1.17 |
LDL | IHWESASLLR | C3 | 0.00061261 | 0.062486488 | 1.14 |
LDL | TLDPER | C3 | 0.00678427 | 0.345997683 | 1.21 |
LDL | GNYDAAQR | Serum amyloid A4 | 0.01222158 | 0.415533787 | 1.04 |
LDL | ALSNVEGFER | Integrin alpha 2B | 0.01827252 | 0.465949135 | 0.84 |
LDL | EALQGVGDMGR | Serum amyloid A4 | 0.02575496 | 0.52540128 | 1.06 |
LDL | VGYVSGWGR | Haptoglobin | 0.04077834 | 0.693231851 | 1.1 |
VLDL | TTSGIHPK | chemokine (C-X-C motif) ligand 7 | 0.0324837 | 0.998795424 | 1.17 |